bullish
Takeda/Shire I : On Drug Deals and Deckchairs
564 Views09 May 2018 21:19
What was rumored, approached, rejected, re-offered and rejected twice more, then agreed.... is now official. Takeda Pharmaceutical Co Ltd (4502 JP)...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 13-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Takeda/Shire III : EGM Announced, Drug Deal Coming Together01 Oct 2018
- Takeda/Shire II: Drugs, Divvies, and AGM Votes02 Jul 2018
- Takeda FVE Reduction Leaves Shares Slightly Undervalued; Shire Acquisition Neutral to Valuation16 May 2018
- Takeda/Shire I : On Drug Deals and Deckchairs09 May 2018
- Takeda Acquires Shire for US$64 Billion – We Continue Our Support of the Deal08 May 2018
- No Deal Is a Big Deal for Takeda25 Apr 2018
x